Reed Elsevier PLC
27 April 2005
ISSUED ON BEHALF OF REED ELSEVIER PLC AND REED ELSEVIER NV
Interests in shares
Reed Elsevier received notification today from Hill Samuel Offshore Trust
Company Limited, the Trustees of the Reed Elsevier Employee Benefit Trust ('the
Trust'), that between 19 April and 21 April 2005 they purchased 33,373 Reed
Elsevier PLC American Depositary Shares ('ADRs') at a prices between $40.2040
and $40.5881 per ADR (equivalent to 133,492 Reed Elsevier PLC ordinary shares).
The transactions took place in order to meet the future exercise of share option
entitlements by employees of Reed Elsevier. Following the transactions, the
Trust now holds an interest in 8,875,473 ordinary shares in Reed Elsevier PLC
and 3,780,057 ordinary shares in Reed Elsevier NV.
The Trust is a discretionary employee benefit trust which is operated in
conjunction with Reed Elsevier's share option schemes, and which provides for
the transfer of shares to employees on the exercise of options granted under the
said schemes. Executive directors of Reed Elsevier PLC and Reed Elsevier NV are,
for technical disclosure purposes, deemed to be interested in the shares held by
the Trust, by virtue of being potential beneficiaries under the Trust.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.